build mutants protocol of discovery studio 3.5 Search Results


90
Retrogen Inc consensus and mutant oligonucleotide of sm α actin sre
Consensus And Mutant Oligonucleotide Of Sm α Actin Sre, supplied by Retrogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/consensus+and+mutant+oligonucleotide+of+sm+%CE%B1+actin+sre/pmc01942159-120-8-24
Average 90 stars, based on 1 article reviews
consensus and mutant oligonucleotide of sm α actin sre - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
New England Biolabs mutant allele
Mutant Allele, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/MboII/bio_rxiv__2024__01__25__577235-236-19-25
Average 95 stars, based on 1 article reviews
mutant allele - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

97
ATCC streptococcus mutans
Streptococcus Mutans, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/Streptococcus+mutans/pm36678812-69-24-26
Average 97 stars, based on 1 article reviews
streptococcus mutans - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

90
ATCC 53907 35 563 m168 20 aec resistant mga3 mutant
53907 35 563 M168 20 Aec Resistant Mga3 Mutant, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/Chryseomonas+luteola+(Kodama+et+al%2E)+Holmes+et+al/10__1128_slash_aem__05093___11-378-71-70
Average 90 stars, based on 1 article reviews
53907 35 563 m168 20 aec resistant mga3 mutant - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

97
ATCC atcc 35 668
Atcc 35 668, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/Streptococcus+mutans+Clarke/pm41015276-93-2-2
Average 97 stars, based on 1 article reviews
atcc 35 668 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

94
ATCC streptococcus uberis 0140j
Streptococcus Uberis 0140j, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/Streptococcus+uberis/pmc03605045__d___69___00451___sup1-2-35-71
Average 94 stars, based on 1 article reviews
streptococcus uberis 0140j - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

sk142  (ATCC)
99
ATCC sk142
Sk142, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/Streptococcus+mutans+Clarke/10__1128_slash_aem__01111___16-198-59-67
Average 99 stars, based on 1 article reviews
sk142 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
ATCC mutant hek293s gnti cells 35
FIGURE 2. Strategy for ST6GAL1 expression, purification, and tag/glycan cleavage. A diagrammatic representation of the coding region for the recombi- nant ST6GAL1 fusion protein expression product is shown at the top of the figure. The expression construct encoded a fusion protein containing an NH2- terminal signal sequence followed by an His8 tag, AviTag, superfolder GFP, TEV protease cleavage site, and the catalytic domain of ST6GAL1 (see “Experimental Procedures” for details). Expression of the recombinant product in <t>HEK293S</t> cells resulted in the secretion of the fusion protein into the culture medium (crude media, lower panel), and subsequent Ni-NTA purification yielded a highly enriched enzyme preparation (IMAC1 elution, lower panel). Cleavage of the enzyme with TEV protease and EndoF1 resulted in removal of tag sequences and glycans down to a single GlcNAc residue attached to the peptide backbone (TEV EndoF1, lower panel). Chromatography over Ni-NTA resulted in the elution of the ST6GAL1 catalytic domain and retention of the tag sequences, TEV protease, and EndoF1 on the column by virtue of their His tags (IMAC2 elution). The enzyme was further purified over Superdex-75, and peak fractions from the gel filtration column are shown in the lower panel. The final pool of purified ST6GAL1 (gel filtration pool) resulted in an 80% yield from the crude culture medium.
Mutant Hek293s Gnti Cells 35, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/HEK293S+GnTI/10__1074_slash_jbc__m113__519041-69-11-16
Average 99 stars, based on 1 article reviews
mutant hek293s gnti cells 35 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

93
Addgene inc mouse dnmt3b deletion mutants
FIGURE 2. Strategy for ST6GAL1 expression, purification, and tag/glycan cleavage. A diagrammatic representation of the coding region for the recombi- nant ST6GAL1 fusion protein expression product is shown at the top of the figure. The expression construct encoded a fusion protein containing an NH2- terminal signal sequence followed by an His8 tag, AviTag, superfolder GFP, TEV protease cleavage site, and the catalytic domain of ST6GAL1 (see “Experimental Procedures” for details). Expression of the recombinant product in <t>HEK293S</t> cells resulted in the secretion of the fusion protein into the culture medium (crude media, lower panel), and subsequent Ni-NTA purification yielded a highly enriched enzyme preparation (IMAC1 elution, lower panel). Cleavage of the enzyme with TEV protease and EndoF1 resulted in removal of tag sequences and glycans down to a single GlcNAc residue attached to the peptide backbone (TEV EndoF1, lower panel). Chromatography over Ni-NTA resulted in the elution of the ST6GAL1 catalytic domain and retention of the tag sequences, TEV protease, and EndoF1 on the column by virtue of their His tags (IMAC2 elution). The enzyme was further purified over Superdex-75, and peak fractions from the gel filtration column are shown in the lower panel. The final pool of purified ST6GAL1 (gel filtration pool) resulted in an 80% yield from the crude culture medium.
Mouse Dnmt3b Deletion Mutants, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/DNMT3B+(3QKJ)+(Plasmid+%2332044)/10__1074_slash_jbc__m110__155721-59-19-9
Average 93 stars, based on 1 article reviews
mouse dnmt3b deletion mutants - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
BioResource International Inc mutant mouse lines
FIGURE 2. Strategy for ST6GAL1 expression, purification, and tag/glycan cleavage. A diagrammatic representation of the coding region for the recombi- nant ST6GAL1 fusion protein expression product is shown at the top of the figure. The expression construct encoded a fusion protein containing an NH2- terminal signal sequence followed by an His8 tag, AviTag, superfolder GFP, TEV protease cleavage site, and the catalytic domain of ST6GAL1 (see “Experimental Procedures” for details). Expression of the recombinant product in <t>HEK293S</t> cells resulted in the secretion of the fusion protein into the culture medium (crude media, lower panel), and subsequent Ni-NTA purification yielded a highly enriched enzyme preparation (IMAC1 elution, lower panel). Cleavage of the enzyme with TEV protease and EndoF1 resulted in removal of tag sequences and glycans down to a single GlcNAc residue attached to the peptide backbone (TEV EndoF1, lower panel). Chromatography over Ni-NTA resulted in the elution of the ST6GAL1 catalytic domain and retention of the tag sequences, TEV protease, and EndoF1 on the column by virtue of their His tags (IMAC2 elution). The enzyme was further purified over Superdex-75, and peak fractions from the gel filtration column are shown in the lower panel. The final pool of purified ST6GAL1 (gel filtration pool) resulted in an 80% yield from the crude culture medium.
Mutant Mouse Lines, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/mutant+mouse+strains/pm19015917-67-2-13
Average 90 stars, based on 1 article reviews
mutant mouse lines - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Mutant Mouse Resource & Research Center breeder mice
FIGURE 2. Strategy for ST6GAL1 expression, purification, and tag/glycan cleavage. A diagrammatic representation of the coding region for the recombi- nant ST6GAL1 fusion protein expression product is shown at the top of the figure. The expression construct encoded a fusion protein containing an NH2- terminal signal sequence followed by an His8 tag, AviTag, superfolder GFP, TEV protease cleavage site, and the catalytic domain of ST6GAL1 (see “Experimental Procedures” for details). Expression of the recombinant product in <t>HEK293S</t> cells resulted in the secretion of the fusion protein into the culture medium (crude media, lower panel), and subsequent Ni-NTA purification yielded a highly enriched enzyme preparation (IMAC1 elution, lower panel). Cleavage of the enzyme with TEV protease and EndoF1 resulted in removal of tag sequences and glycans down to a single GlcNAc residue attached to the peptide backbone (TEV EndoF1, lower panel). Chromatography over Ni-NTA resulted in the elution of the ST6GAL1 catalytic domain and retention of the tag sequences, TEV protease, and EndoF1 on the column by virtue of their His tags (IMAC2 elution). The enzyme was further purified over Superdex-75, and peak fractions from the gel filtration column are shown in the lower panel. The final pool of purified ST6GAL1 (gel filtration pool) resulted in an 80% yield from the crude culture medium.
Breeder Mice, supplied by Mutant Mouse Resource & Research Center, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/build+mutants+protocol+of+discovery+studio+3%2E5/breeder+mice/pm41892628-74-3-15
Average 86 stars, based on 1 article reviews
breeder mice - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


FIGURE 2. Strategy for ST6GAL1 expression, purification, and tag/glycan cleavage. A diagrammatic representation of the coding region for the recombi- nant ST6GAL1 fusion protein expression product is shown at the top of the figure. The expression construct encoded a fusion protein containing an NH2- terminal signal sequence followed by an His8 tag, AviTag, superfolder GFP, TEV protease cleavage site, and the catalytic domain of ST6GAL1 (see “Experimental Procedures” for details). Expression of the recombinant product in HEK293S cells resulted in the secretion of the fusion protein into the culture medium (crude media, lower panel), and subsequent Ni-NTA purification yielded a highly enriched enzyme preparation (IMAC1 elution, lower panel). Cleavage of the enzyme with TEV protease and EndoF1 resulted in removal of tag sequences and glycans down to a single GlcNAc residue attached to the peptide backbone (TEV EndoF1, lower panel). Chromatography over Ni-NTA resulted in the elution of the ST6GAL1 catalytic domain and retention of the tag sequences, TEV protease, and EndoF1 on the column by virtue of their His tags (IMAC2 elution). The enzyme was further purified over Superdex-75, and peak fractions from the gel filtration column are shown in the lower panel. The final pool of purified ST6GAL1 (gel filtration pool) resulted in an 80% yield from the crude culture medium.

Journal: Journal of Biological Chemistry

Article Title: Enzymatic Basis for N-Glycan Sialylation

doi: 10.1074/jbc.m113.519041

Figure Lengend Snippet: FIGURE 2. Strategy for ST6GAL1 expression, purification, and tag/glycan cleavage. A diagrammatic representation of the coding region for the recombi- nant ST6GAL1 fusion protein expression product is shown at the top of the figure. The expression construct encoded a fusion protein containing an NH2- terminal signal sequence followed by an His8 tag, AviTag, superfolder GFP, TEV protease cleavage site, and the catalytic domain of ST6GAL1 (see “Experimental Procedures” for details). Expression of the recombinant product in HEK293S cells resulted in the secretion of the fusion protein into the culture medium (crude media, lower panel), and subsequent Ni-NTA purification yielded a highly enriched enzyme preparation (IMAC1 elution, lower panel). Cleavage of the enzyme with TEV protease and EndoF1 resulted in removal of tag sequences and glycans down to a single GlcNAc residue attached to the peptide backbone (TEV EndoF1, lower panel). Chromatography over Ni-NTA resulted in the elution of the ST6GAL1 catalytic domain and retention of the tag sequences, TEV protease, and EndoF1 on the column by virtue of their His tags (IMAC2 elution). The enzyme was further purified over Superdex-75, and peak fractions from the gel filtration column are shown in the lower panel. The final pool of purified ST6GAL1 (gel filtration pool) resulted in an 80% yield from the crude culture medium.

Article Snippet: Wild type suspension culture HEK293 cells (FreeStyle 293-F cells, Invitrogen) or mutant HEK293S GnTI cells (35) (ATCC catalog no. CRL-3022) were maintained at 0.5–3.0 106 cells/ml in a humidified CO2 platform shaker incubator at 37 °C.

Techniques: Expressing, Purification, Glycoproteomics, Construct, Sequencing, Recombinant, Residue, Chromatography, Filtration